Developing a method to assist investment decisions in specialised commissioning

Closed 11 May 2016

Opened 12 Apr 2016

Contact

Jeremy Glyde

(Head of Strategic Change Management (Specialised Services))

Specialised Commissioning

england.scengagement@nhs.net

Results updated 11 Oct 2017

In April 2016 NHS England held a second public consultation called Developing a Method to Assist Investment Decisions in Specialised Services. This consultation set out a method that it was proposed would be used by the Clinical Priorities Advisory Group when making recommendations on investment decisions for 2016/17. NHS England’s response to consultation (June 2016) confirmed that the method would be adopted for 2016/17 and it described how learning from that year’s commissioning round would inform the development of the method for future years, including through further stakeholder engagement where appropriate. Published documents relating to this consultation are:

Links:

Overview

NHS England is consulting on a method which we propose is used by NHS England's Clinical Priorities Advisory Group when comparing competing priorities when it meets to agree recommendations on the relative prioritisation of new investments in specialised services.

IMPORTANT NOTE: In line with standard requirements regarding transparency of payments by the pharmaceutical industry, all respondents should disclose any payments, grants or other funding received by their recipient or their organisation from the pharmaceutical industry in the last three years, specifying the source of funding and sums involved in each of the last three years.

Audiences

  • All NHS England Staff
  • Charities
  • Patients

Interests

  • Patient and public voice
  • Reducing health inequalities
  • Specialised commissioning